Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO0202
Host Cell : CHO-K1 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO0202 |
| Description | This cell line is engineered to stably overexpress the monkey CTLA4 in CHO-K1 cells. |
| Introduction | This cell line is constructed by transfection of monkey cytotoxic T-lymphocyte associated protein 4 (CTLA4) into CHO-K1, followed by stable cell selection. The expression of CTLA4 has been analyzed through flow cytometry. |
| Target Gene | CTLA4 |
| Host Cell | CHO-K1 |
| Host Cell Species | Cricetulus griseus (Chinese hamster) |
| Applications |
1. Studying the interactions between immune cells and cancer cells 2. Studying the mechanisms of resistance to immune checkpoint blockade 3. High-throughput screening 4. Drug target validation |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
A: This cell line is established based on specific types of monkey cells (usually macaque or rhesus monkey cells), by stably integrating the CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) gene into these cells.
A: This cell line can be used to study the immunoregulatory functions of CTLA4, especially in cancer immunotherapy and autoimmune disease research.
A: The expression level of CTLA4 in this cell line is specially designed to mimic the natural expression level in immune cells in vivo, facilitating the study of CTLA4 function under physiological conditions.
A: It is primarily used for screening and evaluating the effects of small molecule drugs, antibodies, or other therapeutic agents targeting CTLA4, especially in anti-tumor immunotherapy.
A: Due to the stable expression of the CTLA4 gene, this cell line is particularly suitable for studying the activation and regulation of CTLA4 signaling pathways and their roles in immune responses.
A: Its biosafety must be comprehensively assessed through cytotoxicity tests, pathogen detection, and genetic stability testing.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.